Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Waverley Pharma Inc
V.WAVE
Healthcare
Biotechnology
Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution...
agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:WAVE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(1)
•••
nomoney
X
View Profile
View Bullboard History
Comment by
nomoney
on Aug 05, 2020 10:15am
RE:RE:RE:Scotia has the worst platform to do online banking
What really irks me is that they can't even have a message on the site saying that they are experiencing problems and working to fix them. How many investors unfamiliar with Scotia's
...more
(15)
•••
bullmarkets
X
View Profile
View Bullboard History
Comment by
bullmarkets
on Aug 05, 2020 10:10am
RE:L2 shows that at envy point MM could take it to 0.28
People pumping at the highs and selling at the lows -- this will be 50 cents plus this month imo. So it's a great buy in weakness
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Aug 05, 2020 10:00am
L2 shows that at envy point MM could take it to 0.28
I'm going to call it , expect close before the weekend at 0.25-0.29
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Comment by
moneywinner1
on Aug 05, 2020 9:34am
RE:Wave’s Cancer drug approved in EU, soon FDA approval
FDA approval coming soon,
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Aug 05, 2020 9:02am
Chart tells all the story
Wave forming similar patterns like last time before the huge run , I expect news very soon
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Aug 05, 2020 8:53am
Char tells the story
Just look at it
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Aug 05, 2020 8:26am
Wave’s Cancer drug approved in EU, soon FDA approval
Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European Countries
(6)
•••
Grose1987
X
View Profile
View Bullboard History
Comment by
Grose1987
on Aug 04, 2020 5:00pm
RE:RE:RE:Pumpers plenty
Ahh you pulled the trigger. Looked like it was strong around .20 I added today aswell at .21 and .23
(63)
•••
Dollarpee
X
View Profile
View Bullboard History
Post by
Dollarpee
on Aug 04, 2020 4:49pm
Fully funded Research + UofM + revenue stream + low float
Are the reasons why I am here holding tight patiently waiting for it to explode. If it's not real, it won't receive funding!! Average down to 0.24
(15)
•••
bullmarkets
X
View Profile
View Bullboard History
Comment by
bullmarkets
on Aug 04, 2020 3:52pm
RE:RE:Pumpers plenty
Ok I am in 22 average -- guess we got to wait for news.
(333)
•••
DeadPool007
X
View Profile
View Bullboard History
Post by
DeadPool007
on Aug 04, 2020 3:25pm
Catalyst
What's the next few catalyst we can expect for $WAVE?
(184)
•••
north40
X
View Profile
View Bullboard History
Comment by
north40
on Aug 04, 2020 1:45pm
RE:RE:Scotia has the worst platform to do online banking
Horrible all morning! i clicked on and all my stocks,rrsp,tfsa vanished, so minor league. missed a buy this morning on nxo, missed a sell on rvv, is there No accountability?
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Aug 04, 2020 1:31pm
Wave soon get USA FDA approval for Cancer drug sales
Huge news on the horizon
(15)
•••
bullmarkets
X
View Profile
View Bullboard History
Comment by
bullmarkets
on Aug 04, 2020 1:16pm
RE:Pumpers plenty
Building a base and not much selling, might actually buy this thing since it's not selling off
(16)
•••
Horn1369
X
View Profile
View Bullboard History
Post by
Horn1369
on Aug 04, 2020 1:11pm
Revenue from UK's NHS alone should be a big boost.
For the share price. We should see the numbers from EU in next Qs. GL Products: Waverley Pharma Inc. has a collaboration with Reliance Life Sciences Private Limited (RLS) part of a
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden